30 Day Trial

BARE BONES content is posted to these pages in real time.

Monthly compilations are available in PDF form.

Product / Company Performance

Kuros Biosciences: First Procedure in MagnetOS Spinal Fusion Trial -

The first patient was treated in a multicenter study comparing Kuros Bioscience's MagnetOs bone graft substitute vs. autologous bone in spinal fusion.The blinded, controlled, randomized multicenter trial is scheduled to enroll 100 patients in the Netherlands. Enrollment began in 2H18. The primary objective is to demonstrate non-inferiority in efficacy and safety of MagnetOs. (Kuros Biosciences, 9/27/18)